Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma

被引:2
作者
Peller, S [1 ]
Halperin, R
Schneider, D
Kopilova, Y
Rotter, V
机构
[1] Assaf Harofeh Med Ctr, Dept Hematol, IL-70300 Zerifin, Israel
[2] Assaf Harofeh Med Ctr, Dept Gynecol, IL-70300 Zerifin, Israel
[3] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel
关键词
p53 tumor suppressor gene; p53; polymorphism; ovarian carcinoma; endometrial; carcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p53 gene is frequently mutated in various human tumors. Polymorphism is an additional genetic alteration observed in exons and introns of the p53 gene of normal tissues and tumors. Distributions of alleles of three common polymorphisms of the p53 gene; a 16 bp duplication in intron 3, codon 72 of exon 4 and a sequence in intron 6, were studied in peripheral white blood cells (WBC) of patients with ovarian or endometrial carcinomas. The analysis was performed by PCR and direct sequencing. The 100% linkage observed between the most common haplotypes of each polymorphism in healthy subjects was lower in the patients. A significant difference was observed between frequencies of genotype and haplotype combinations in patients with ovarian carcinoma and endometrial carcinoma. The incidence of heterozygosity was increased in ovarian carcinoma and decreased in endometrial carcinoma. Our results suggest that the p53 gene may be involved in susceptibility and predisposition to various cancers not only by mutations but also by preferential presentation of polymorphic alleles.
引用
收藏
页码:193 / 197
页数:5
相关论文
共 28 条
[1]   PCR DETECTION OF A NEUTRAL CGA/CGG DIMORPHISM IN EXON-6 OF THE HUMAN P53 GENE [J].
BHATIA, K ;
GUTIERREZ, MI ;
HUPPI, K ;
MAGRATH, IT .
NUCLEIC ACIDS RESEARCH, 1992, 20 (04) :928-928
[2]   P53 POLYMORPHISMS AND HAPLOTYPES IN LUNG-CANCER [J].
BIRGANDER, R ;
SJALANDER, A ;
RANNUG, A ;
ALEXANDRIE, AK ;
SUNDBERG, MI ;
SEIDEGARD, J ;
TORNLING, G ;
BECKMAN, G ;
BECKMAN, L .
CARCINOGENESIS, 1995, 16 (09) :2233-2236
[3]  
Caron De Fromentel Claude, 1992, Genes Chromosomes and Cancer, V4, P1
[4]  
FELLEYBOSCO E, 1993, AM J HUM GENET, V53, P752
[5]  
HAHN M, 1993, CLIN CHEM, V39, P549
[6]   MOLECULAR-BASIS FOR HETEROGENEITY OF THE HUMAN P53-PROTEIN [J].
HARRIS, N ;
BRILL, E ;
SHOHAT, O ;
PROKOCIMER, M ;
WOLF, D ;
ARAI, N ;
ROTTER, V .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (12) :4650-4656
[7]   PROGNOSTIC-SIGNIFICANCE OF P53 IMMUNOSTAINING IN EPITHELIAL OVARIAN-CANCER [J].
HARTMANN, LC ;
PODRATZ, KC ;
KEENEY, GL ;
KAMEL, NA ;
EDMONSON, JH ;
GRILL, JP ;
SU, JQ ;
KATZMANN, JA ;
ROCHE, PC .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) :64-69
[8]   P53 EXPRESSION IN EPITHELIAL OVARIAN NEOPLASMS - RELATIONSHIP TO CLINICAL AND PATHOLOGICAL PARAMETERS, KI-67 EXPRESSION AND FLOW-CYTOMETRY [J].
HENRIKSEN, R ;
STRANG, P ;
WILANDER, E ;
BACKSTROM, T ;
TRIBUKAIT, B ;
OBERG, K .
GYNECOLOGIC ONCOLOGY, 1994, 53 (03) :301-306
[9]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[10]   GERM-LINE POLYMORPHISMS OF P53 AND CYP1A1 GENES INVOLVED IN HUMAN LUNG-CANCER [J].
KAWAJIRI, K ;
NAKACHI, K ;
IMAI, K ;
WATANABE, J ;
HAYASHI, SI .
CARCINOGENESIS, 1993, 14 (06) :1085-1089